Last updated: 2026-10-13 10:26:40. Prices reflect the latest pre-market trading data. Stock price data is sourced from Massive.
Clene Inc. (CLNN) operates in the PHARMACEUTICAL PREPARATIONS sector and is listed on NASDAQ. The stock is currently priced at $3.75, with a market capitalisation of $54.87M and a P/E ratio of --. Over the past 52 weeks, its price has ranged from $3.25 to $13.50. This page covers its latest market performance, valuation, price trends and company information.
$54.87M | |
$3.93 | |
$356.40 | |
$2.28 | |
$3.86 | |
70.46K | |
100.95K | |
-- | |
$13.50 | |
$3.25 | |
-- | |
-- |
Clene Inc. (CLNN) is trading at $3.85 in pre-market trading as of 2026-10-12 23:17:00, down 0.26% ($0.01) from the previous close of $3.86
Pre-market trading shows how investors are pricing CLNN before the regular session opens. The current pre-market price is near the previous close, indicating cautious early trading sentiment.
Over the past seven days, Clene Inc. (CLNN) moved from $4.08 to $3.75, representing a decline of 8.21% ($0.33).
The stock traded between $3.67 and $4.17 during the period. The latest price is near the lower end of the 7-day range, indicating strong downward.
The average daily volume was 90.01 thousand shares, up versus the previous seven-day period, indicating higher trading activity.
Position in Range: 4.8%
CLNN is currently trading at $3.75, placing it 4.8% of the way from its 52-week low of $3.25 to its 52-week high of $13.50. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.
Clene Inc is a clinical-stage pharmaceutical company pioneering the discovery, development, and commercialization of novel clean-surfaced nanotechnology (CSN) therapeutics. It is focused on the development of therapeutics for neurodegenerative diseases. It developed an electro-crystal-chemistry drug development platform that enables the production of concentrated, stable, clean-surfaced nanocrystal suspensions. It operates in one segment the development and commercialization of dietary supplements (Supplements). Products includes CNM-Au8, CNM-ZnA, CNM-AgZn17, rMetx, KHC46.
| Industry | PHARMACEUTICAL PREPARATIONS |
| Employees | 79 |
| Exchange | NASDAQ |
| Company Website |
Eligible investors can buy real shares of Clene Inc. (CLNN) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.